BiotechTube
DNA Software

DNA Software

Ann Arbor, United States· Est.
dnasoftware.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3M

Overview

DNA Software is a pioneering private company that provides AI-driven software solutions for PCR assay design, significantly reducing development time and cost for its clients. Its technology platform, built on over two decades of research, enables the automated design of complex singleplex and multiplex PCR assays with high specificity and sensitivity. The company operates a dual business model, selling its software directly and offering high-value consulting and assay design services. Its tools are critical for applications in infectious disease, oncology, and personalized medicine, positioning it as an enabler for diagnostic and biotechnology companies.

Infectious DiseaseOncologyGenetic Disorders

Technology Platform

Suite of AI/ML-powered software (PanelPlex™, Consensus™, Visual OMP™) for in silico design, simulation, and optimization of singleplex and multiplex PCR assays, focusing on specificity, sensitivity, and homology differentiation.

Funding History

2
Total raised:$3M
Grant$500K
Seed$2.5M

Opportunities

The growing demand for complex multiplex diagnostic panels in infectious disease and oncology, coupled with the trend towards personalized medicine, creates a significant market for DNA Software's precision assay design tools.
The expansion into selling physical PCR kits via PCRassays.com represents a new, scalable revenue stream that leverages its core design expertise.

Risk Factors

The company's focus is dependent on the sustained dominance of PCR technology, facing potential long-term disruption from alternative detection methods.
Competition from other commercial and open-source PCR design tools requires continuous innovation to maintain a technical edge.
The new PCR kit e-commerce venture introduces execution risks in manufacturing and distribution.

Competitive Landscape

DNA Software competes in the niche market of advanced PCR assay design software against other commercial packages and open-source tools (e.g., Primer3). Its primary competitive advantage is its specialized focus on complex multiplexing and homology differentiation, validated by peer-reviewed research and decades of experience. Larger life science tools companies may offer more basic, integrated design utilities.

More companies in Diagnostics & Precision Medicine →More companies in United States →